Asensus Surgical Inc (ASXC) Stock Price & Overview
NYSEARCA:ASXC • US04367G1031
The current stock price of ASXC is 0.3479 USD. Today ASXC is up by 0.64%. In the past month the price increased by 2.9%. In the past year, price increased by 23.37%.
ASXC Key Statistics
- Market Cap
- 94.624M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.28
- Dividend Yield
- N/A
ASXC Stock Performance
ASXC Stock Chart
ASXC Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ASXC. When comparing the yearly performance of all stocks, ASXC is one of the better performing stocks in the market, outperforming 91.45% of all stocks.
ASXC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ASXC. While ASXC seems to be doing ok healthwise, there are quite some concerns on its profitability.
ASXC Earnings
On August 13, 2024 ASXC reported an EPS of -0.09 and a revenue of 2.21M. The company missed EPS expectations (-47.06% surprise) and beat revenue expectations (75.72% surprise).
ASXC Forecast & Estimates
7 analysts have analysed ASXC and the average price target is 0.36 USD. This implies a price increase of 2.62% is expected in the next year compared to the current price of 0.3479.
For the next year, analysts expect an EPS growth of 21.03% and a revenue growth 43.58% for ASXC
ASXC Groups
Sector & Classification
ASXC Financial Highlights
Over the last trailing twelve months ASXC reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS increased by 17.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -192.86% | ||
| ROE | -604.36% | ||
| Debt/Equity | 0 |
ASXC Ownership
ASXC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.61 | 195.75B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.29 | 175.278B | ||
| SYK | STRYKER CORP | 24.19 | 140.034B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.56 | 106.692B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.34 | 48.896B | ||
| IDXX | IDEXX LABORATORIES INC | 41.18 | 48.604B | ||
| BDX | BECTON DICKINSON AND CO | 12.14 | 47.113B | ||
| RMD | RESMED INC | 20.6 | 36.847B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.63 | 34.468B | ||
| DXCM | DEXCOM INC | 27.04 | 26.455B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11 | 18.25B | ||
| PODD | INSULET CORP | 37.18 | 16.923B | ||
| HOLX | HOLOGIC INC | 15.4 | 16.875B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ASXC
Company Profile
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 207 full-time employees. The company operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. The company is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. The company is also working to incorporate all of this in the LUNA Surgical System.
Company Info
IPO: 1991-08-06
Asensus Surgical Inc
1 Tw Alexander Drive, Suite 160
Durham NORTH CAROLINA 27703 US
CEO: Anthony Fernando
Employees: 207
Phone: 19197658400
Asensus Surgical Inc / ASXC FAQ
What does ASXC do?
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 207 full-time employees. The company operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. The company is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. The company is also working to incorporate all of this in the LUNA Surgical System.
What is the current price of ASXC stock?
The current stock price of ASXC is 0.3479 USD. The price increased by 0.64% in the last trading session.
Does Asensus Surgical Inc pay dividends?
ASXC does not pay a dividend.
What is the ChartMill technical and fundamental rating of ASXC stock?
ASXC has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Is Asensus Surgical Inc (ASXC) expected to grow?
The Revenue of Asensus Surgical Inc (ASXC) is expected to grow by 43.58% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.